CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Yield10 Bioscience, Inc.  (MBLX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

MBLX's Operating Income Growth by Quarter and Year

Yield10 Bioscience,'s Operating Income results by quarter and year




MBLX Operating Income (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - -2.53 2.09 -5.90
III Quarter September -2.66 -1.98 -2.60 -5.88
II Quarter June -2.42 -2.71 -3.23 -6.13
I Quarter March -2.31 -2.06 -6.50 -5.83
FY   -7.39 -9.28 -10.24 -23.74



MBLX Operating Income third quarter 2018 Y/Y Growth Comment
Yield10 Bioscience, Inc. in the third quarter recorded Operating Loss of $ -2.66 millions.

According to the results reported in the third quarter, Yield10 Bioscience, Inc. achieved the best Operating Income growth in Medical Laboratories industry. While Yield10 Bioscience, Inc.' s Operating Income no change of % ranks overall at the positon no. in the third quarter.

Explain Operating Income growth


MBLX Operating Income ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Yield10 Bioscience,'s third quarter 2018 Operating Income $ 0.00 millions MBLX's Income Statement
Yield10 Bioscience,'s third quarter 2017 Operating Income $ 0.00 millions Quarterly MBLX's Income Statement
New: More MBLX's historic Operating Income Growth >>


MBLX Operating Income (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Yield10 Bioscience,'s Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MBLX's III. Quarter Q/Q Operating Income Comment
III. Quarter 2018 results of -2.66 millions by Yield10 Bioscience, Inc. look even less good considering the -2.42 millions Operating Loss in the previous quarter.

Within Medical Laboratories industry Yield10 Bioscience, Inc. achieved highest sequential Operating Income growth. While Yield10 Bioscience,'s Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MBLX's III. Quarter Q/Q Operating Income Comment
Recent results of -2.66 millions by Yield10 Bioscience, Inc. appear even worse considering the -2.42 millions Operating Loss in the second quarter.

Within Medical Laboratories industry Yield10 Bioscience, Inc. achieved highest sequential Operating Income growth. While Yield10 Bioscience,'s Operating Income growth quarter on quarter, overall rank is .


Yield10 Bioscience,'s 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
Cumulative Operating Income 12 Months Ending $ -9.92 $ -9.24 $ -9.53 $ -9.28 $ -4.67
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Yield10 Bioscience, Inc.' has realized cumulative trailing twelve months Operating Loss of $ -10 millions in the Sep 30 2018 period.
The results are detiriorating as the cumulative Operating Loss is inflating from $ -9.24 millions in the twelve months ending a quarter before and $ -2.42 millions for the twelve months ending in the quarter a year ago.

Yield10 Bioscience, Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Yield10 Bioscience, Inc.' has realized cumulative trailing twelve months Operating Loss of $ -10 millions in the Sep 30 2018 period.
The results are getting worse as the cumulative Operating Loss is inflating from $ -9.24 millions for the period from Jun 30 2018 to Sep 30 2017 and $ -2.42 millions from the TTM period ending Sep 30 2017.

Yield10 Bioscience, Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


You need to upgrade your Flash Player




Other Operating Income Growth
Medical Laboratories Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
MBLX's Operating Income Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for MBLX's Competitors
Operating Income Growth for Yield10 Bioscience,'s Suppliers
Operating Income Growth for MBLX's Customers

You may also want to know
MBLX's Annual Growth Rates MBLX's Profitability Ratios MBLX's Asset Turnover Ratio MBLX's Dividend Growth
MBLX's Roe MBLX's Valuation Ratios MBLX's Financial Strength Ratios MBLX's Dividend Payout Ratio
MBLX's Roa MBLX's Inventory Turnover Ratio MBLX's Growth Rates MBLX's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2018 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2018
Alpha Pro Tech Ltd  58.65 %$ 58.655 millions
Abiomed Inc  58.61 %$ 58.608 millions
Medpace Holdings, Inc.  56.52 %$ 56.518 millions
Celgene Corp  54.84 %$ 54.839 millions
Exelixis, Inc.  54.20 %$ 54.196 millions
Staar Surgical Co  51.77 %$ 51.774 millions
Radnet, Inc.  51.75 %$ 51.748 millions
Orasure Technologies Inc  48.34 %$ 48.340 millions
Biospecifics Technologies Corp  44.92 %$ 44.923 millions
Innoviva, Inc.  44.07 %$ 44.073 millions
Synergy Chc Corp.  43.75 %$ 43.750 millions
Universal Hospital Services Inc  38.56 %$ 38.562 millions
Bruker Corp  38.48 %$ 38.477 millions
Intricon Corp  37.55 %$ 37.551 millions
Shire Plc  34.89 %$ 34.886 millions
Baxter International Inc  31.85 %$ 31.849 millions
Luna Innovations Inc  31.30 %$ 31.300 millions
Resmed Inc  28.05 %$ 28.051 millions
Align Technology Inc  26.78 %$ 26.776 millions
Inogen Inc  24.77 %$ 24.772 millions
Protokinetix, Inc.  24.26 %$ 24.259 millions
Repro Med Systems Inc  23.02 %$ 23.016 millions
Abbott Laboratories  22.84 %$ 22.840 millions
Electromed, Inc.  22.56 %$ 22.561 millions
U S Physical Therapy Inc  19.75 %$ 19.747 millions
Tenax Therapeutics, Inc.  18.60 %$ 18.604 millions
Ait Therapeutics, Inc.  17.31 %$ 17.307 millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ADGO's Profile

Stock Price

ADGO's Financials

Business Description

Fundamentals

Charts & Quotes

ADGO's News

Suppliers

ADGO's Competitors

Customers & Markets

Economic Indicators

ADGO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071